A seven-month feeding trial with genetically modified (GM) Roundup Ready® (RRS ® ) soybeans was conducted on Atlantic salmon (initial weight 40 g) going through the parr-smolt transformation. The maternal near-isogenic soybean line was used as a non-modified control (non-GM), and the two diets were compositionally similar in all analysed nutrients. The performance and health of the fish were assessed by growth, body composition, organ development, haematological parameters, clinical plasma chemistry and lysozyme levels, with samples collected both in the freshwater-and seawater stages. Intestinal indices exhibited some differences between the groups, with the mid-intestine being consistently smaller in the GM fed fish throughout the experiment, while the distal intestine was different at one sampling point, shortly after seawater transfer. Plasma triacylglycerol (TAG) levels were higher in the GM group overall in the experiment, although the magnitude of the difference was larger around the time of seawater transfer compared to later samplings. Despite differences at individual sampling points, there were no differences in total growth during the trial. All other measured parameters showed no diet related differences. Seawater transfer caused changes in gill Na + K + -ATPase activity and plasma chloride ion concentration, as well as in haematological parameters (red blood cell count, RBC, haematocrit, Hct, haemoglobin, Hb) and plasma glucose concentration. However, both diet groups responded similarly regarding these parameters. Our overall conclusion is that the observed effects of feeding Atlantic salmon with GM soy at a 25% inclusion level were minor, and lack of consistency with previous studies suggests that they might be caused by variations in the soy strains rather than the genetic modification per se.
Introduction
With increasingly limited availability of fish meal, the inclusion of alternative protein sources in fish feeds is a necessity from both an economic and an environmental perspective (FAO, 2005) . Soybean meal has become a common ingredient in commercial feed for Atlantic salmon and many other fish species. Soy has a high protein content and relatively well balanced amino acid profile compared to many other plant products, but there are difficulties regarding the content of anti-nutrients and the availability of non-genetically modified (non-GM) products (Francis et al., 2001a; Kaushik and Hemre, 2008) . The most common variety of GM soy is Roundup Ready® (RRS®) which has been modified to express the protein CP4 enolpyruvylshikimate-3-phosphate synthase (EPSPS), making the plant resistant to herbicides containing glyphosate (Padgette et al., 1995) . The use of GM plants in fish diets has so far been avoided by the aquaculture industry in Europe. However, increasing prices and difficulty of obtaining non-GM products are forcing feed producers to reconsider. Potential hazards with the use of GM-products can be divided into two main categories; intrinsic properties and functions of the introduced trait (intended change, e.g. toxicity or allergenicity of the novel protein) and possible unintended changes (EFSA, 2008) . Unintended changes result from the random insertion of a transgene into the host genome, which might disrupt endogenous gene expression and thus result in changed levels of macro-or micronutrients, anti-nutritional factors or other differences (Cellini et al., 2004) .
The number of feeding studies conducted with GM plants on fish is limited. There have been evaluations of methionine enhanced GM lupin fed to red seabream (Pagrus auratus) (Glencross et al., 2003) , glyphosate-tolerant canola fed to Rainbow trout (Oncorhynchus mykiss) (Brown et al., 2003) , and Bt maize fed to Atlantic salmon Hemre et al., 2007) . Reduced growth, coupled with indications of a mild stress response were reported in the GM fed fish from one of the maize-trials Sagstad et al., 2007) , from the other trials no negative effects were reported. However, case-by-case assessment of GM events has been advocated (Kuiper et al., 2001; Larkin and Harrigan, 2007) , and is the standard both in Norway (Food Safety Authority), and the EU (EFSA; European Food Safety Authority), as different GM plants express different transgenic proteins and potentially have different unintended changes. Thus, feeding trials with RRS® are the most relevant for comparison. Such experiments have not revealed major effects on performance, organ function and fish health related to GM soy, the observed effects have generally been minor and may not deviate from the normal physiological range for the species in question (see below). This might be related to the short duration of the studies (Hammond et al., 1996; Sagstad et al., 2008) or the moderate inclusion levels of the GM soy Sanden et al., 2006) . In addition to long term studies with high inclusion levels, investigations including a greater range of health-related parameters are needed. For instance, Hammond et al. (1996) measured only growth, survival and fillet composition in catfish fed GM soy for 10 weeks, and (Chainark et al., 2006) looked at growth, feed performance and whole body composition in rainbow trout fed GM soy for 3 months. This may not provide sufficient information to conclude on the safety or nutritional equivalence of the GM soy compared to traditional soy varieties.
In a 3 month study with 17% (13% of total protein) inclusion of RRS® for Atlantic salmon, lysozyme levels in head kidney (p = 0.06) (Bakke-McKellep et al., 2007a) and spleen weights (p b 0.05) were elevated compared to fish fed the non-GM soy diet, the latter parameter not significantly different from fish fed a fish meal reference diet. This study was conducted with a commercial soy variety as control, not the maternal line of the GM soy. Thus differences in the soy cultivars were suggested as a potential confounding factor (Bakke-McKellep et al., 2007a) , and there is a need to verify whether observed differences are due to variations between different lines of the crop plant rather than GM per se. In a 28-day feeding trial conducted with 15 and 30% inclusion levels of RRS® and the nearisogenic maternal soy-line, the spleen was found to be significantly larger in groups fed GM soy, while the plasma triacylglycerol (TAG) level was lower (Sagstad et al., 2008) . A study conducted on first feeding Atlantic salmon for 7 months (12.5% RRS®, 7% of total protein, commercial soy as control) found that the proportion of epithelial cells undergoing proliferation (proliferating cell nuclear antigen [PCNA]-positive cells) was higher in intestinal sections from fish fed the non-GM diet (Sanden et al., 2006) . In all of these studies, a multitude of differences were found between the soy-diets and the fish meal based reference diets used. However, with the exception of the parameters mentioned above, responses were independent of whether the soy used was GM or not. Thus, they can probably be ascribed to general soy-effects, such as the inflammatory response in the distal intestine of salmon fed soybean meal (Van den Ingh et al., 1991; Baeverfjord and Krogdahl, 1996) . Working with mice, Malatesta and co-workers have reported morphological changes in hepatocytes and changes in the liver proteome of animals fed diets containing GM soybean (Malatesta et al., 2002; Malatesta et al., 2008a) . However, these effects might be ascribed to glyphosate residues present in the GM soybeans used (Malatesta et al., 2008b) .
A particularly sensitive stage in the life cycle of Atlantic salmon is the parr-smolt transformation, a process enabling the fish to migrate from freshwater to seawater. This process comprises a range of preparatory, physiological adaptations for seawater entry, and involves changes such as increase in hypoosmotic regulatory ability, and hormonal, metabolic, morphological and behavioural changes (for review see Hoar, 1988; Boeuf, 1993) . Successful accomplishment of the parr-smolt transformation depends on nutritional status and energy turnover above a certain level (Thorpe et al., 1998) . Investigations of responses to dietary exposure to GM feed ingredients during potentially sensitive developmental stages, such as parr-smolt transformation, are necessary steps in the progression toward a full safety assessment.
Based on some of the inconclusive results from previous trials there is a need for further studies using the maternal isogenic line as control. This study was designed to be a long-term study (7 months) with a relatively high inclusion level of GM soy (25%, constituting 21% of the total protein) conducted on fish before, during and after the parr-smolt transformation. Growth, body composition, organ indices, haematological parameters, plasma enzymes and nutrients, and lysozyme levels in spleen and head kidney during the parr-and smolt stages were measured to assess the production performance and general health of salmon fed RRS® in the long term. Osmoregulatory ability of fish undergoing smoltification while fed the different diets was evaluated by measurements of gill Na + K + -ATPase activity and plasma chloride concentration before and after seawater transfer. Table 1 shows the composition of the full fat soybean meal (FFSBM) used, the formulation of the experimental diets and their proximate compositions. RRS® (modification event GTS 40-3-2) and its non-GM maternal near-isogenic line (supplied by the Monsanto Company, St. Louis, MO, USA) were included at a 25% and 26.2% level in the two respective diets. The diets were composed to be nutritionally and compositionally equivalent, and soy oil was added to the GM diet to balance for higher lipid content in the non-GM soybeans. The proportion of protein from soy in both diets was 21%, while fishmeal was the main source of protein. Addition of vitamins and minerals was done according to NRC recommendations (NRC, 1993) . The soybeans were processed and the diets (2 mm and 3 mm pellet batches) were produced by Skretting ARC (Stavanger, Norway). The feed was produced by means of a Wegner TX-57 twin-screw extruder (80-95°C), and the process also included preconditioning and drying at 80-85 and 80-100°C, respectively.
Materials and methods

Diet composition
Fish rearing and experimental design
The feeding trial was conducted in accordance with Norwegian laws and regulations concerning experiments with live animals, and took place at the Institute of Marine Research (Matredal, 61°N, Western Norway). The salmon were hatched in February, and in July 960 parr were randomly distributed in eight 300 l experimental tanks and acclimated for 3 weeks while fed a commercial feed free of GMO (Ewos, 2 mm). The trial commenced on August 11th, with 4 replicate tanks for each diet regime. The fish were fed in excess with continuous feeding from automated feeders. Feeding was regulated by a feed table (Skretting), taking total biomass, fish size and water temperature into account. Manual adjustments were made based on the amount of uneaten feed. The trial lasted close to 7 months, until 28th of February.
The light regime was adjusted to the parr-smolt transformation; a square wave photoperiod regime was used, which is widely used in practical production to obtain out-of-season smolt. The fish were initially reared at continuous light (from first feeding), followed by a "winter signal" (Light:Dark [LD] 12:12) for 8 weeks, and then 6 weeks of "summer" (LD 24:0). At this time, which was assumed to be peak smoltification, the fish were transferred directly from fresh water to full strength seawater (35‰ salinity) in 400 l tanks. For the remainder of the trial, the fish were exposed to continuous light. The temperature followed natural fluctuations in the water intake, averaging 9.9°C for the entire period. Oxygen levels were maintained above 80% saturation throughout the trial (average 88.7%). The water flow was about 20 l/min in the freshwater phase and about 23 l/min in the seawater phase. Fig. 1 gives an overview of the experimental design, with an initial sampling before the trial commenced and four experimental samplings during the course of the trial. Fish were in feeding status at all samplings. At the samplings in September and December fish were anesthetized (Benzoak® VET, 0.2 ml/L, ACD Pharmaceuticals, Leknes, Norway) and killed by a blow to the head. At the two samplings in February, the fish could not be anesthetised due to plans on further use of the fillet in a rat feeding trial, and were simply killed by a quick blow to the head. Body weight and length were measured on individual fish (15 per tank per sampling). Blood was drawn from the caudal vessel (Vena caudalis) by means of a heparinized medical syringe (5 per tank, 6 at the final sampling), before organs were dissected out. Liver, head-kidney, spleen (5 per tank, 6 at the final sampling) and intestinal parts (7 per tank, 6 at the final sampling) were also weighed. Prior to weighing, the intestinal tract was cleaned of visceral fat and luminal content, and was then divided into the proximal (the part of the intestine from which the pyloric caeca originate), mid and distal intestine. Fish for proximal analysis were frozen whole on dry ice (3 per tank). At seawater transfer, a time lag between the transfer of each tank ensured that the time from transfer to the samples were taken was exactly the same for each tank. Blood and gill tissue samples were collected the day before transfer ("0 h", coinciding with sampling 2) and at 24 and 96 h after transfer to assess the ability of the fish to maintain/re-establish homeostasis and osmotic balance after seawater transfer (3 fish per tank).
Chemical analysis of diets and whole fish
Moisture was measured by drying at 103°C for 24 h, ash weighed after burning at 540°C and lipid after extraction with ethyl-acetate (Lie, 1991) . Nitrogen was measured with a nitrogen determinator (LECO, FP-428) according to AOAC official methods of analysis (AOAC, 1995) and protein calculated as N × 6.25. Starch was measured by enzymatic degradation as described by Hemre et al. (1989) . Amino acids (Cohen and Strydom, 1988 ) and vitamin B 6 (CEN, 2002) were determined by HPLC (high performance liquid chromatography) methods and fatty acids by GLC (gas liquid chromatography) (Lie and Lambertsen, 1991) . Multi-element determination in the feed was done by ICP-MS (inductively coupled plasma mass spectrometry) (Julshamn et al., 1999) .
Haematology, plasma enzymes and nutrients
Of the blood, 200 μl were kept as individual samples for haematology, while the remainder was centrifuged at 3000 g for 10 min to obtain the plasma fraction, which was flash frozen in liquid nitrogen and stored at −80°C. Hematocrit (Hct) was immediately measured using Vitex Pari microhaematocrit tubes and a Hettich centrifuge (type 201424). Red blood cells (RBC) and haemoglobin (Hb) were measured on a Cell-Dyn 400 (Sequoia-Turner) according to the manufacturer's instructions, using Para 12 control blood (Streck) for calibration. The indices mean cell volume (MCV), mean cell haemoglobin (MCH) and mean cell haemoglobin concentration (MCHC) were calculated according to (Sandnes et al., 1988) . Analyses of the plasma enzymes lactate dehydrogenase (LDH), alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) and the nutrients glucose, total protein and triacyl glycerol (TAG) concentrations were performed on Maxmat Biomedical Analyser (SM1167, Maxmat S.A., France), using Maxmat reagents and the appropriate calibrators and controls for the different methods.
Differential white blood cell count (WBCC)
The blood smears were prepared on glass microscope slides, airdried and fixed in absolute methanol for 5 min, then stained with May-Grünwald (Merck) for 5 min and Giemsa (Merck) for 15 min. The samples were blinded and examined with an Olympus light microscope (BX 51) at 400×. 100 white blood cells were counted for each fish and each cell classified either as lymphocyte, granulocyte or monocyte. Fig. 1 . Overview of the experimental design of the 7 month feeding trial with GM and nGM soy. The graph shows the mean growth during the trial (for both diet groups combined as they did not differ significantly), the time point for the samplings, seawater transfer, cross-over of diet groups and the stress test. The light regime is also given in the figure.
Lysozyme activity
Levels of lysozyme were determined in homogenised spleen and head kidney samples by use of a turbidimetric microplate technique with the Gram-positive bacterium Micrococcus lysodeikticus (Sigma no A-7906) in suspension (0.2 mg mL − 1 ). Calibration was performed with hen egg white lysozyme (Ellis, 1990 ) and the lysozyme activity was then calculated relative to tissue weight. Each sample was run in 5 replicates on the plate, and the absorbance was measured at 450 nm. (1993), where hydrolysis of ATP to ADP is enzymatically linked to the oxidation of NADH which is quantified in a plate reader. In short, frozen gill filaments (0.1 g in SEIbuffer: 0.15 M sucrose, 0.01 M Na 2 EDTA, 0.05 M imidazole, pH 7.4) were homogenised, centrifuged and the supernatant collected. Samples were run in two sets of 4 replicates (with and without the inhibitor ouabain in the assay mixture) in 96-well microplates and read in a plate reader at 340 nm at 21°C. The difference in rate of NADH oxidation between the two sets was used to calculate Na + K + -ATPase activity, by means of an ADP standard curve. The results were normalized to total protein content in each sample, determined by BCA (bicinchoninic acid) assay kit (Pierce, Rockford, USA) based on colorimetric quantification of total protein (Smith et al., 1985) .
Gill Na
Calculations
Condition factor (K) = (bw/fl 3 ) ⁎ 100 (bw = body weight, fl = fork length) Organosomatic index = (ow/bw) ⁎ 100 (ow = organ weight) Specific growth rate = (lnW f − lnW i ⁎ 100) / t (W f = final weight, W i = initial weight, t = time in days) Thermal growth coefficient = 1000 
Statistics
All statistical analyses of the data were performed using Statistica™ 8.0 software (Statsoft, Inc. Tulsa, USA). Data fulfilling the assumptions of homogeneity of variance and normal distribution (tested by Levene's and Shapiro Wilk tests, respectively) were subjected to nested ANOVA, with the tank as random effect and the diet as fixed effect. For the results from the seawater-challenge, a twoway nested ANOVA was used, with both diet and time point as fixed factors and tank as random factor. For organ indices and blood parameters, an overall analysis including all the samplings was conducted with nested ANOVA with tank as random effect and diet and sampling point as fixed effects. Overall analysis of plasma values was done with a two-way ANOVA on tank means/pooled samples. Arcsine transformation was used for the numbers from the WBCC as binary data summarized as proportions violates the assumption of homogeneity of variance (Zar, 1999) . Two-tailed tests were used, and the critical level for significance was set at 0.05. However, all p-values below 0.10 are given in the tables.
Results
Diets
The diets were analysed to ensure equivalence in terms of macronutrient levels, fatty acid and amino acid profiles, minerals and vitamin B 6 as a representative of the vitamins (Tables 1-4) . Based on the analysed nutrients the diets were compositionally equivalent as the variations between them were below the expected analytical variation for the different methods used. For example, the differences in fat and protein content between the two diets were smaller than the difference between the two parallels analysed for each diet sample. The fatty acid profiles showed a slightly lower n-3/n-6 ratio in the non-GM feed (1.63 versus 1.86); this was mainly due to small differences in linoleic and linolenic acid, while the levels of the essential fatty acids eicosapentaenoic acid (EPA) and decosahexaenoic acid (DHA) were very similar between the diets.
Growth and survival
Growth during the trial is reported in Table 5 . A significant difference was seen in the weight of the sampled fish at the 2nd sampling (December) with the GM fed fish being heavier (p = 0.04), and in the growth rate from this point until the subsequent sampling, with the non-GM fish having a better growth (p = 0.02). No Table 2 Fatty acid composition of the experimental diets. nGM = non genetically modified near isogenic maternal soy line, GM = genetically modified soy. All numbers are given as % of total fatty acids (except the n−3/n−6 ratio).
differences were seen at the other samplings, nor was there a difference in the final weight or over-all growth rate during the entire trial between the two groups. The growth rate varied throughout the trial, compared to the parr stage with continuous light it decreased markedly in the period from when the "winter" light regime was initiated until seawater transfer, and increased again thereafter. The experiment passed without unexpected events, with the exception of an accident resulting in the death of 23 fish in one of the tanks. At the following sampling the data from this tank were tested for differences to the other tanks before they were included in the general analyses. Apart from this, two fish died during the parr stage of unknown cause (both from the non-GM diet, different tanks), and two fish were removed from the trial prior to seawater transfer as they were sexually mature dwarf males and would not survive in seawater (one from the GM and one from the non-GM diet).
Proximate composition and organ indices
Proximate composition (fat, protein, ash and dry matter) of whole fish revealed no differences between the diet groups at any sampling (Table 6 ). The level of protein in whole body was relatively constant throughout the trial, whereas the level of lipid was higher in the freshwater phase compared to early seawater phase.
For the organ indices (Table 7) , no significant diet effects were observed for the spleen (SSI), liver (HSI), head kidney (HKSI) or proximal intestine (PISI). The mid intestine (MISI) was heavier in the non-GM fed fish throughout the experiment, significant at sampling 2 in December (p = 0.035) and at the final sampling in February (p = 0.0039). The distal intestine (DISI) was significantly larger in the GM fed fish at sampling 3 (February) (p = 0.018), while otherwise there was no clear tendency throughout the experiment; the index varied randomly between the two diet groups in the different samplings. Overall in the entire experiment (all sampling points included in the same analysis) the mid intestine was significantly larger in the non-GM group (p = 0.009), no differences were seen for any of the other organs.
The spleen-somatic index was very constant throughout the trial and also exhibited minimal differences between the two diet groups. The hepatosomatic index decreased towards the parr-smolt transformation and increased again thereafter. The relative size of the head kidney increased steadily throughout the trial. For all the three intestinal segments (proximal, mid and distal intestine), there was a rapid increase in size after seawater transfer, particularly for the proximal intestine which increased 150% in size from sampling 2 (the day before seawater transfer) to the final sampling (77 days later). The mid and distal intestine sizes increased 82% and 61%, respectively (averaged numbers from both diet groups). Numbers are given in mg/g feed, as the mean of two analytical parallels. nGM = non genetically modified near isogenic maternal soy line, GM = genetically modified soy. Numbers are the average of two analytical parallels and are given as mg/kg feed. LOQ = limit of quantification. 
Blood parameters, lysozyme and plasma
The haematological values (Table 8) showed no diet-induced differences, neither at individual sampling points, nor over-all for the entire experiment. There were fluctuations in all these parameters between samplings, but these were comparable between the two diet groups. Differential white blood cells counts from stained blood smears (Table 9 , Fig. 2 ) revealed no differences in proportions of lymphocytes, granulocytes and monocytes between the diet groups. Lysozyme levels in spleen and head kidney (Table 10) were not affected by diet. For this parameter there were significant tank effects with relatively large differences between tanks, but there was no clear correlation between high lysozyme levels in head kidney and in spleen between the tanks.
No differences in diet treatments were observed in the plasma enzymes ASAT, ALAT or LDH, nor in plasma protein or glucose (Table 8) . Plasma TAG was consistently higher in the GM group compared to the non-GM group at all samplings when plasma was collected (sampling 2, 3 and 4). This difference was statistically significant in December when all the three time points (before, 24 h and 96 h after seawater transfer) were included (p = 0.0001) (Table 11 ). When only the main sampling in December was included the p-value was 0.067 (Table 8) . At the later samplings (3 and 4, both in February), the magnitude of the difference was smaller, and at these samplings the plasma samples were also pooled in order to measure more parameters. Over-all in the entire experiment (all samplings included) TAG levels were significantly higher in the GM group (p = 0.025). During the experiment, the plasma TAG and protein levels increased with time in both diet groups, while glucose showed a decreasing trend. For the enzyme biomarkers of cell integrity of liver and/or muscle, i.e. ASAT, ALAT and LDH, no time trends can be seen as these were only measured at the two last samplings.
Seawater transfer
Based on the measured parameters, there were no differences between the two diet groups in how they coped with seawater transfer (Table 11) . However, there were differences between values before and after seawater transfer. Most of the haematological parameters were affected by transfer; RBC (p = 0.002) and Hct (p = 0.048) both decreased from 0 h to 24 and 96 h, while Hb (p = 0.002) decreased from 0 to 24 h and then decreased even further to 96 h. At 96 h MCHC was lower than at 0 h (p = 0.020), while the Mean values (SD). Blood: 5 fish per tank (6 at the final sampling), 4 tanks per treatment, were analysed for haematocrit (Hct), red blood cell count (rbc), haemoglobin (Hb), mean cell volume (MCV), mean cell haemoglobin (MCH) and mean cell haemoglobin concentration (MCHC). Plasma: individual samples were used at sampling 2, pooled for each tank at sampling 3 and 4 (5 fish per tank, 6 at the final sampling). nGM = non genetically modified near isogenic maternal soy line, GM = genetically modified soy. No blood samples were collected at the initial sampling, due to the small size of the fish. Proportions of granulocytes, lymphocytes and monocytes of 100 white blood cells classified. 5 fish in each tank, 4 tanks per treatment, were examined from blood samples taken at the final sampling. nGM = non genetically modified near isogenic maternal soy line, GM = genetically modified soy. Values are given as mean (SD).
24 h point was not significantly different from either of the two. The glucose level in the plasma decreased markedly from 0 h to 24 h and 96 h (p b 0.0001), there was also a further decrease from 24 to 96 h, but this was not significant. Plasma protein and TAG levels were not affected by transfer. The chloride ion concentration in plasma increased from 0 to 24 h, but was regulated back to the initial level within 96 h (p = 0.004). There were two outliers at the 24 h point (two fish from two different non-GM tanks) with very high values, if these are removed from the analysis the value at 24 h would be 24.4 (3.5), but this time point would still be significantly different from 0 and 96 h (p b 0.0001). Both including and excluding the two outliers, there is no difference between the two diet groups. Na + K + -ATPase activity in the gill tissue had a small, but not significant, decrease from before seawater transfer to 24 h after, while at 96 h after transfer there was a large increase (p b 0.0001). At the time of transfer, morphological signs were consistent with the parr-smolt transformation; silver coloring, loss of "parr marks", dark fin margins and more developed fins.
Discussion
The GM soy (RRS®) and its near-isogenic maternal line exhibited small differences in protein and lipid content, but similar composition of the diets was achieved. Despite being the closest possible control that can be obtained, variations in nutrient composition between GM plants and their near-isogenic maternal lines have also been observed by others (Aulrich et al., 2001; Sagstad et al., 2008) .
The slow growth can be attributed to the numerous samplings with handling stress as well as to the high soy content in the diet, neither of which provide optimal conditions for growth (Refstie et al., 1998; Bakke-McKellep et al., 2006) . The depressed growth rate of the fish when exposed to the "winter signal" until seawater transfer is comparable to what has been observed in other studies, and low growth is found to continue even after return to 24 h light (Sigholt et al., 1998; Handeland and Stefansson, 2002) . Towards the end of the smoltification period, salmon normally have reduced weight gain and increasingly linear growth (Boeuf, 1993) . There are conflicting results on protein requirements during the parr and smolt stages. GrisdaleHelland and Helland (1997) found that a minimum of 55% protein (of dry matter) was required for parr to achieve maximum growth, but during smolting levels down to 47% did not reduce growth (Helland and Grisdale-Helland, 1998) . Conversely, Nordgarden et al. (2002) found depressed growth during the parr-smolt transformation in diets with 50 and 54% protein compared to 58%. However, the fish on the 50 and 54% diets in that study experienced a depletion of muscle protein, which was not the case in our fish as judged from stable levels of whole body protein. We therefore conclude that protein levels in both diet groups were sufficient for growth during this period.
Significantly higher weight of the GM fed fish at a single sampling point followed by a significantly higher growth rate in the other group until the next sampling, suggests that a random occurrence where many small fish were sampled for the non-GM group (or many large for the GM group) caused both of these apparent effects.
The lipid level in whole fish and the hepatosomatic index decreased during the parr-smolt transformation, probably to meet energy demands during this process. It is known that the parr-smolt transformation entails a depletion of energy stores from muscle and liver (Sheridan, 1989) . It might be that a higher dietary lipid level would have reduced the need to use body reserves (Nordgarden et al., 2002) . However, a higher lipid level was difficult to obtain with the high levels of soy, which was the target ingredient in this study. The high residue content in the FFSBM limited the amount of protein and lipid possible to obtain in the feed. The inclusion of extracted SBM (20% of crude protein) has been shown to lead to a somewhat Only one blood smear is shown, as we found no difference between diet groups. For further details see Table 8 . The smear is stained with May-Grünwald/Giemsa. depressed growth, but still supported successful physiological adjustments and development through smoltification and good osmoregulatory ability in seawater . In that study the feed had about 8% higher lipid level than in the present.
There were no diet related differences in organ indices except in the mid-and distal intestine, thus not supporting earlier findings of enlarged spleen in salmon fed GM soy Sagstad et al., 2008) . The effect on the distal intestine was only observed at one sampling, there was no similar trend at the other samplings and no difference overall in the trial. This suggests that the effect is either a random occurrence or an adaptive response in that particular developmental stage (early seawater). Adaptive responses are characterised by being reversible and of limited duration, and are not considered to be adverse effects by EFSA (2008) . The parr-smolt transformation is a period where substantial changes occur in the intestine, which is a major osmoregulatory organ and is changing its role from preventing inflow of water in the freshwater stage to actively absorbing ions and water in the seawater stage (Sundell et al., 2003) . The distal intestine is the site where SBM-induced inflammation occurs, and SBM diets have been reported to decrease both total weight and mucosal fold height (Van den Ingh et al., 1991; Baeverfjord and Krogdahl, 1996; Nordrum et al., 2000) . The inflammation was shown to decline in the short term when SBM-fed fish were transferred from freshwater to seawater, most likely due to decreased feed intake and thus exposure to the causatory agent(s) present in soy . The development of the intestine during this stage is reflected in the rapid changes in relative size observed in this experiment. Sanden et al. (2005) and (BakkeMcKellep et al., 2007b) detected increased cell proliferation in the distal intestine of salmon fed SBM. A larger number of cells were undergoing proliferation when fed conventional compared to GM soy, but the authors explained this may be due to the different origins of the soy material .
Different from the distal intestine, the effect on the mid intestine exhibited a consistent pattern through all the samplings and was significantly different overall in the experiment, with a lower relative weight in the GM group. Explanations for this are not evident in the existing data material. A comparable effect on the mid intestine was not observed (neither significant effects nor a detectable trend) in other studies with RRS® fed to Atlantic salmon with either a non-GM commercial soy line or the maternal line as control (Sagstad et al., 2008) . According to EFSA (2008) , differences (between animals fed GM and control diet) are neither considered to be of any toxicological relevance nor to represent adverse effects as long as the values are within the normal physiology in the species. Intestinal indices for GM soy-fed Atlantic salmon have been reported both in the freshwater and seawater phase Sanden et al., 2005) , but as the intestinal indices change so rapidly through development, comparisons are hard to make. The fish were fed until sampling, as soy-induced enteritis in Atlantic salmon has been shown to be quickly reversed when the fish is no longer fed soybean meal and fasting of salmon causes a rapid decrease in intestinal tissue mass, protein and enzyme capacities (Baeverfjord and Krogdahl, 1996; Krogdahl and Bakke-McKellep, 2005) . Sagstad et al. (2008) found lower levels of plasma TAG in fish fed GM soy compared to non-GM soy. This is contrary to the present results, with elevated plasma TAG in the GM group, suggesting that this difference is not related to the genetic modification per se. Alternative explanations could be found in differences in levels of herbicide residues or minor differences in nutritional qualities such as anti-nutritional factors in the different soy strains. Saponins were suggested to be the cause by Sagstad et al. (2008) . There are reports that alcohol-soluble components in soy (which include saponins) reduce lipid digestibility in Atlantic salmon (Olli and Krogdahl, 1995) , and elevated muscle cholesterol has been observed in tilapia given Quillaja saponin mixture in the diet (Francis et al., 2001b) . The TAG levels in fish fed both diets were within the range of values reported in the literature for healthy salmon of similar size Nordgarden et al., 2002) , thus not defined as an adverse effect according to EFSA (2008) . Nevertheless, detected changes can provide clues as to other processes that might have been adversely affected and require additional studies (EFSA, 2008) . The contradictory nature of our results to the results of Sagstad et al. (2008) suggests that this is not a "GM-effect", but rather related to natural variations in levels of anti-nutritional factors, antigens, metabolites or other unknown factors in the plants.
Red blood cell indices (RBC, Hg, Hct) were not affected by GM soy in our study with salmon, although they have been shown to be influenced by dietary factors, such as protein and lipid content (Rehulka and Parova, 2000) or astaxanthin supplement (Rehulka, 2000) . The screening of haematological parameters is a sensitive, but not always a very specific, measure of fish health (Blaxhall and Daisley, 1973) , reflected in our data by the fact that nearly all haematological parameters were affected by seawater transfer (although affected equally in both diet groups). The transaminases ALAT and ASAT are located within tissue cells and have no known function in plasma. When all membranes are intact, these are present in plasma in only low concentrations (Tietz, 1976) . Higher concentrations are indicative of cell damage, and plasma levels of these enzymes have proven useful in the diagnosis of liver and kidney diseases in fish (Racicot et al., 1975) . None of the transaminases exhibited changes related to GM in the diet. Despite deviation from reference values reported in adult salmon (Sandnes et al., 1988) , the present values were slightly lower than reported in salmon at a similar developmental stage (Hemre and Hansen, 1998) , indicating healthy liver and kidney function in both diet groups. Earlier findings have suggested a GM effect on the pattern of lymphocytes and granulocytes when fed Bt-maize, event MON810 . This was, however, not observed in the current study when the salmon were fed GM soy. Likewise, the tendency towards elevated lysozyme levels in the head-kidney observed in salmon fed GM soy (Bakke-McKellep et al., 2007a) was not confirmed in this study.
This rapid recovery to homeostasis after seawater transfer indicates that the fish were physiologically ready, and the fish in both diet groups responded equally well. Additionally, our growth rate during the initial phase in seawater compares favourably to that reported by others at similar temperature (Handeland et al., 1998) , further supporting that the fish were fully prepared for seawater entry. Na + K + -ATPase activity in the gill tissue and plasma concentration of chloride ions following seawater challenge are widely used methods to describe smolt development (McCormick et al., 2002) . The Na + K + -ATPase activity displayed a (non-significant) decrease 24 h after seawater transfer, as has been shown by others when transfer occurs at low water temperatures (Handeland et al., 2000) . Within 96 h, however, there was a clear up-regulation of this activity in the gill tissue. Similarly, the chloride ion concentration was elevated at 24 h after seawater exposure, but after 96 h the level was the same as the initial level in freshwater.
When interpreting potential GM effects, there is always a danger of confounding factors, such as small compositional differences between the soy varieties, even the near-isogenic maternal line will never be completely identical. The challenge of designing studies and obtaining appropriate controls for inclusion in diets will only increase as GM plants become more complex, with several simultaneous modifications or intended changes in nutrient composition. As of 2007, GM plants with stacked double or triple traits cover 19% of the total area grown with GM crops. This constitutes a 66% growth from 2006 to 2007 and is expected to increase further in the near future (James, 2007) .
The present study was a long term trial to clarify somewhat inconclusive results from earlier trials, as well as assess consequences of longer term feeding and feeding during a physiologically challenging stage of salmon development, the parr-smolt transformation. In conclusion, fish in both diet groups had similar nutritional and health status and managed the adaptation to life in seawater equally well. No adverse effects were observed. Some minor changes observed in other studies with GM soy fed to Atlantic salmon were not confirmed. This lack of reproducibility indicates case-by-case variation, even within the same crop and genetic modification, and that other confounding factors (such as variations in ANFs) rather than genetic modification per se may be involved in the effects observed. The results presented here support and strengthen the conclusion made in earlier studies that GM soy can be used as an equivalent and safe substitute for traditional soy varieties in feeds for Atlantic salmon.
